Research and Training Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on September 28, 2022

Feed last updated: February 01 2023 10:20 pm
Title FOA/Notice Number Issuing Organizationsort descending Release Date Expiration Date Activity Code
Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed) PAR-21-247 NHGRI Jul 12 2021 Jun 16 2023 R43/R44
Genomic Community Resources (U24 Clinical Trial Not Allowed) PAR-20-100 NHGRI Jan 23 2020 May 26 2023 U24
Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations NOT-HG-20-010 NHGRI Jan 13 2020 Oct 05 2023 R01
Notice of NHGRI Participation in PAR-19-372, Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed). NOT-HG-19-026 NHGRI Sep 16 2019 N/A N/A
Notice of Intent to Publish a Funding Opportunity Announcement for Research and Development for Genome Reference Representations (GRR) (U01, Clinical Trial Not Allowed) NOT-HG-19-009 NHGRI Oct 25 2018 N/A N/A
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) RFA-HL-23-014 NHLBI Jan 24 2022 Dec 21 2024 R33
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) RFA-HL-23-013 NHLBI Jan 24 2022 Dec 21 2024 R61/R33
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) RFA-HL-23-012 NHLBI Jan 24 2022 Dec 21 2024 R33
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) RFA-HL-23-011 NHLBI Jan 24 2022 Dec 21 2024 R61/R33
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) RFA-HL-23-010 NHLBI Jan 24 2022 Dec 21 2024 R33
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) PAR-22-034 NHLBI Oct 12 2021 Jul 13 2024 K22
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) PAR-22-040 NHLBI Oct 12 2021 Jul 13 2024 K22
Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed) RFA-HL-24-004 NHLBI Jan 10 2023 Mar 11 2023 R25
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) PAR-22-194 NHLBI Jun 01 2022 Oct 18 2024 X01
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional) PAR-22-077 NIA Dec 22 2021 Oct 18 2024 U54
Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed) PAR-21-212 NIA Mar 23 2021 May 08 2024 U01
Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) PAR-20-156 NIA Mar 31 2020 May 08 2023 R01
Notice of Change to Research Objectives and Award Budget for RFA-AG-20-035 "Building Resources for the Basic Biology of Aging in Health Disparities Research (R24 Clinical Trial Not Allowed)" NOT-AG-19-043 NIA Sep 16 2019 N/A N/A
Alzheimer's-focused administrative supplements for NIH grants that are not focused on Alzheimer's disease NOT-AG-18-039 NIA Nov 26 2018 N/A N/A
Notice of Participation of the National Institute on Aging (NIA) in RFA-MH-19-511 "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)" NOT-AG-18-030 NIA Sep 25 2018 N/A N/A
Notice of Participation of the National Institute on Aging (NIA) in RFA-MH-19-510 "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)" NOT-AG-18-029 NIA Sep 25 2018 N/A N/A
Notice of Intent to Publish a Funding Opportunity Announcement for Alzheimer Centers for Discovery of New Medicines (U54 - Clinical Trial Not Allowed) NOT-AG-18-012 NIA Apr 27 2018 N/A N/A
Notice to Specify High-Priority Research Topics for PAR-18-596 NOT-AG-18-001 NIA Feb 02 2018 N/A N/A
Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) RFA-AI-22-069 NIAID Nov 14 2022 Apr 08 2023 U19
Notice of Intent to Publish a Funding Opportunity Announcement for Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed) NOT-AI-22-051 NIAID May 16 2022 N/A N/A

Pages

XLS